These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 7046776
1. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Atkinson AB, Cumming AM, Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JI. Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776 [Abstract] [Full Text] [Related]
2. Effect of captopril on the renin-angiotensin system in hypertensive children. Friedman AL, Chesney RW. J Pediatr; 1983 Nov; 103(5):806-10. PubMed ID: 6355422 [Abstract] [Full Text] [Related]
3. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)]. Goto A. Nihon Naibunpi Gakkai Zasshi; 1980 Jun 20; 56(6):868-83. PubMed ID: 6997093 [Abstract] [Full Text] [Related]
4. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system. Riegger GA, Steilner H, Hayduk K, Liebau G. Am J Cardiol; 1982 Apr 21; 49(6):1555-7. PubMed ID: 6803566 [Abstract] [Full Text] [Related]
5. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI. Br Heart J; 1980 Sep 21; 44(3):290-6. PubMed ID: 7000102 [Abstract] [Full Text] [Related]
6. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition. Atkinson AB, Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JI. Clin Sci (Lond); 1979 Dec 21; 57 Suppl 5():139s-143s. PubMed ID: 396067 [No Abstract] [Full Text] [Related]
7. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J. Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363 [Abstract] [Full Text] [Related]
8. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension]. Posadas C, Sánchez G, Boyer JL, Delmar M, Serrano PA. Arch Inst Cardiol Mex; 1982 Aug 15; 52(4):295-300. PubMed ID: 6291470 [Abstract] [Full Text] [Related]
9. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril. Atlas SA, Case DB, Yu ZY, Laragh JH. Am J Med; 1984 Aug 20; 77(2A):13-7. PubMed ID: 6089554 [Abstract] [Full Text] [Related]
10. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance. Morton JJ, Tree M, Casals-Stenzel J. Am J Cardiol; 1982 Apr 21; 49(6):1395-400. PubMed ID: 7041583 [Abstract] [Full Text] [Related]
11. [Effects of a single dose of captopril on blood pressure and the renin-angiotensin-aldosterone system in normal subjects and hypertensive patients with various etiologies (author's transl)]. Ogihara T, Maruyama A, Mikami H, Naka T, Higaki J, Kanda T, Gotoh M, Hata T, Kumahara Y. Nihon Jinzo Gakkai Shi; 1979 Nov 21; 21(11):1185-92. PubMed ID: 396402 [No Abstract] [Full Text] [Related]
12. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension. Rasmussen S, Damkjaer Nielsen M, Ibsen H, Leth A, Giese J. Eur J Clin Invest; 1984 Feb 21; 14(1):30-6. PubMed ID: 6321195 [Abstract] [Full Text] [Related]
13. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers. Shepherd AN, Campbell BC, Reid JL. J Cardiovasc Pharmacol; 1982 Feb 21; 4(3):381-7. PubMed ID: 6177933 [Abstract] [Full Text] [Related]
14. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients. Ogihara T, Maruyama A, Hata T, Mikami H, Nakamaru M, Naka T, Ohde H, Kumahara Y. Clin Pharmacol Ther; 1981 Sep 21; 30(3):328-35. PubMed ID: 6268347 [Abstract] [Full Text] [Related]
15. The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients. Manhem P, Bramnert M, Hulthén UL, Hökfelt B. Eur J Clin Invest; 1981 Oct 21; 11(5):389-95. PubMed ID: 6800810 [Abstract] [Full Text] [Related]
16. Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Atkinson AB, Brown JJ, Cumming AM, Fraser R, Lever AF, Leckie BJ, Morton JJ, Robertson JI. Br Med J (Clin Res Ed); 1982 Mar 06; 284(6317):689-93. PubMed ID: 6802290 [Abstract] [Full Text] [Related]
17. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril. Rasmussen S, Leth A, Ibsen H, Damkjaer Nielsen M, Nielsen F, Giese J. Acta Med Scand; 1985 Mar 06; 218(5):435-42. PubMed ID: 3004113 [Abstract] [Full Text] [Related]
18. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system. Santucci A, Aguglia F, De Mattia G, Cammarella I, Giordano M, Gnecchi M, Trinchieri F, Ficara C. Int J Clin Pharmacol Res; 1984 Mar 06; 4(1):41-5. PubMed ID: 6381343 [Abstract] [Full Text] [Related]
19. Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect. Tree M, Morton JJ. Clin Sci (Lond); 1980 Dec 06; 59(6):451-6. PubMed ID: 7002436 [Abstract] [Full Text] [Related]
20. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)]. Shionoiri H, Uneda S, Tochikubo O, Ohonishi T, Harada J, Sesoko S, Goto E, Fujishima S, Kaneko Y. Nihon Jinzo Gakkai Shi; 1980 Jan 06; 22(1):13-22. PubMed ID: 6247528 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]